Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses

BMC Microbiology

Volumn 1, Issue , 2001, Pages 1-11

  Bitko, Vira ^a   Barik, Sailen ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; MESSENGER RNA; MUTANT PROTEIN; NUCLEOTIDE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL ACTIVITY; CORRELATION ANALYSIS; CYTOPLASM; GENE SEQUENCE; GENE SILENCING; GENOME; LIFE CYCLE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA VIRUS; VIRAL GENETICS; WILD TYPE; DRUG EFFECT; GENETICS; METABOLISM;

PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RNA VIRUSES;

GENE SILENCING; PHENOTYPE; RESPIRATORY SYNCYTIAL VIRUSES; RNA VIRUSES; RNA, DOUBLE-STRANDED; RNA, VIRAL;

EID: 19044381013     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-1-34     Document Type: Article

References (34)

1. Hammond SM, Caudy AA, Hannon GJ: Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2001, 2:110-119
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498
3. Banerjee AK, Barik S, De BP: Gene expression of nonsegmented negative-strand RNA viruses. Pharmacol Ther 1991, 51:47-70
4. Cogoni C, Macino G: Post-transcriptional gene silencing across kingdoms. Curr Opin Genet Dev 2000, 10:638-643
5. Geiss G, Jin G, Guo J, Bumgarner R, Katze MG, Sen GC: A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J Biol Chem 2001, 276:30178-30182
6. Kumar M, Carmichael GG: Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol Mol Biol Rev 1998, 62:1415-1434
7. Crowe JE Jr, Bui PT, London WT, Davis AR, Hung PP, Chanock RM, Murphy BR: Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine 1994, 12:691-699
8. Pekosz A, He B, Lamb RA: Reverse genetics of negative-strand RNA viruses: Closing the circle. Proc Natl Acad Sci USA 1999, 96:8804-8806
9. Marriott AC, Easton AJ: Reverse genetics of the Paramyxoviridae. Adv Virus Res 1999, 53:321-340
10. Luytjes W, Krystal M, Enami M, Pavin JD, Palese P: Amplification, expression, and packaging of foreign gene by influenza virus. Cell 1989, 59:1107-1113
11. Whelan SP, Ball LA, Barr JN, Wertz GT: Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci USA 1995, 92:8388-8392
12. Lawson N, Stillman E, Whitt M, Rose J: Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci USA 1995, 92:4477-4481
13. Collins PL, Hill MG, Camargo E, Grosfeld H, Chanock RM, Murphy BR: Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci USA 1995, 92:11563-11567
14. Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dotsch C, Christiansen G, Billeter MA: Rescue of measles viruses from cloned DNA. EMBO J 1995, 14:5773-5784
15. Wertz GM, Howard MB, Davis N, Patton J: The switch from transcription to replication of a negative-strand RNA virus. Cold Spring Harb Symp Quant Biol 1987, 52:367-371
16. Pattnaik AK, Ball LA, LeGrone A, Wertz GW: The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles. Virology 1995, 206:760-764
17. Burke E, Dupuy L, Wall C, Barik S: Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology 1998, 252:137-148
18. Burke E, Mahoney NM, Almo SC, Barik S: Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J Virol 2000, 74:669-675
19. Barik S, McLean T, Dupuy LC: Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: phosphorylation of Ser237 may play an accessory role. Virology 1995, 213:405-412
20. Dupuy LC, Dobson S, Bitko V, Barik S: Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser215 and is without effect. J Virol 1999, 73:8384-8392
21. Mazumder B, Barik S: Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation- defective P mutants. Virology 1994, 205:104-111
22. Yu Q, Hardy RW, Wertz GW: Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J Virol 1995, 69:2412-2419
23. Grosfeld H, Hill MG, Collins PL: RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J Virol 1995, 69:5677-5686
24. de Magalhaes JC, Andrade AA, Silva PN, Sousa LP, Ropert C, Ferreira PC, Kroon EG, Gazzinelli RT, Bonjardim CA: A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J Biol Chem 2001, 276:38353-38360
25. Dramsi S, Cossart P: Intracellular pathogens and the actin cytoskeleton. Annu Rev Cell Dev Biol 1998, 14:137-166
26. Frischknecht F, Moreau V, Rottger S, Gonfloni S, Reckmann I, Superti-Furga G, Way M: Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 1999, 401:926-929
27. Falsey AR, Walsh EE: Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000, 13:371-384
28. Kahn JS: Respiratory syncytial virus vaccine development. Curr Opin Pediatr 2000, 12:257-262
29. Gonzalez-Reyes L, Ruiz-Arguello MB, Garcia-Barreno B, Calder L, Lopez JA, Albar JP, Skehel JJ, Wiley DC, Melero JA: Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci USA 2001, 98:9859-9864
30. Srivastava SP, Davies MV, Kaufman RJ: Calcium depletion from the endoplasmic reticulum activates the double-stranded RNA-dependent protein kinase (PKR) to inhibit protein synthesis. J Biol Chem 1995, 270:16619-16624
31. Bennett CF, Cowsert LM: Application of antisense oligonucle-otides for gene functionalization and target validation. Curr Opin Mol Ther 1999, 1:359-371
32. Moyer SA, Smallwood-Kentro S, Haddad A, Prevec L: Assembly and transcription of synthetic vesicular stomatitis virus nucleo-capsids. J Virol 1991, 65:2170-2178
33. Bitko V, Barik S: An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem 2001, 80:441-454
34. Fuchs B, Zhang K, Schabel A, Bolander ME, Sarkar G: Identification of twenty-two candidate markers for human osteogenic sarcoma. Gene 2001, 278:245-252